Found 3 hits for monomerid = 347496 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347496
![PNG](/data/jpeg/tenK34/BindingDB_347496.png) (US9790180, ID 029)Show SMILES CC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1ccncc1 Show InChI InChI=1S/C29H34N6O3/c1-29(10-14-34(15-11-29)28(37)35-16-18-38-19-17-35)33-24-5-2-22(3-6-24)27(36)32-26-20-23(4-7-25(26)30)21-8-12-31-13-9-21/h2-9,12-13,20,33H,10-11,14-19,30H2,1H3,(H,32,36) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this Ligand-Target Pair | |
Histone deacetylase 3
(Homo sapiens (Human)) | BDBM347496
![PNG](/data/jpeg/tenK34/BindingDB_347496.png) (US9790180, ID 029)Show SMILES CC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1ccncc1 Show InChI InChI=1S/C29H34N6O3/c1-29(10-14-34(15-11-29)28(37)35-16-18-38-19-17-35)33-24-5-2-22(3-6-24)27(36)32-26-20-23(4-7-25(26)30)21-8-12-31-13-9-21/h2-9,12-13,20,33H,10-11,14-19,30H2,1H3,(H,32,36) | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 541 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this Ligand-Target Pair | |
Histone deacetylase 2
(Homo sapiens (Human)) | BDBM347496
![PNG](/data/jpeg/tenK34/BindingDB_347496.png) (US9790180, ID 029)Show SMILES CC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1ccncc1 Show InChI InChI=1S/C29H34N6O3/c1-29(10-14-34(15-11-29)28(37)35-16-18-38-19-17-35)33-24-5-2-22(3-6-24)27(36)32-26-20-23(4-7-25(26)30)21-8-12-31-13-9-21/h2-9,12-13,20,33H,10-11,14-19,30H2,1H3,(H,32,36) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this Ligand-Target Pair | |